Investing.com - Bio-Rad Labs B (NYSE: BIOb) reported third quarter EPS of $2.33, $0.43 worse than the analyst estimate of $2.76. Revenue for the quarter came in at $632.12M versus the consensus estimate of $689.5M.
Bio-Rad Labs B's stock price closed at $301.00. It is up 0% in the last 3 months and down -22.99% in the last 12 months.
Bio-Rad Labs B saw positive EPS revisions and negative EPS revisions in the last 90 days. See Bio-Rad Labs B's stock price’s past reactions to earnings here.
According to InvestingPro, Bio-Rad Labs B's Financial Health score is "good performance".
Check out Bio-Rad Labs B's recent earnings performance, and Bio-Rad Labs B's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar